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Introduction 
In Malawi, Acquired Immunodeficiency Syndrome (AIDS) is 
a major cause of  death among 15 - 49 year olds. It is estimated 
that 900,000 adults and children live with HIV/AIDS in 
Malawi, a country where the HIV/AIDS prevalence in adults 
(15-49 years) was 14.1% in 20051,2.In  2005, an estimated 
170,000 people were in immediate need of  antiretroviral 
therapy (ART) with children below 15 years accounting 
for nearly 15% of  the those needing ART in Malawi3.   In 
2001, the Ministry of  Health (MoH) introduced subsidized 
antiretrovirals (ARVs) in three referral hospitals in the three 
regions of  Malawi, rapidly scaling up national access to free 
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p r o g r a m m e 
focused almost 
entirely on 
adults2,3.  A 
majority of  
HIV- infected 
infants and 
children were treated symptomatically in the general 
paediatric clinics with few receiving treatment through the 
adult ART programme.   
The Baylor College of  Medicine-Abbott Fund Children’s 
Clinical Centre of  Excellence-Malawi (COE) is the first stand-
alone clinic in Malawi dedicated to the care and treatment 
of  HIV-infected children, and training of  different cadres 
of  health professionals in the management of  paediatric 
HIV/AIDS4. The COE is part of  a network of  clinics 
established by the Baylor International Paediatric AIDS 
Initiative (BIPAI) whose headquarters is in Houston, Texas, 
United States of  America. The BIPAI network comprises 
of  centres of  excellence in Romania, Botswana, Lesotho, 
Uganda, Swaziland, and Malawi that provide care and 
treatment to HIV-infected children and families who qualify 
to be enrolled in the family clinic. Two additional centres of  
excellence are in the processes of  being established in Kenya 
and Burkina Faso. BIPAI is also working with partners in 
Libya and Tanzania. The Malawi COE is located within the 
grounds of  Kamuzu Central Hospital (KCH), a government 
facility in Lilongwe. The COE was officially opened on 2nd 
November, 2006. The COE is operated by a locally registered 
trust known as Baylor College of  Medicine Children’s 
Foundation - Malawi.
Patient care and training
The clinical and training functions of  the programme are 
categorized into five levels: 1) patient care and training 
activities at the COE; 2) patient care at outreach sites in 
Lilongwe district; 3) patient care, training and supervision at 
outreach sites in all the other districts in the central region 
of  Malawi; 4) patient care, training and supervision at distant 
sites in the southern and northern regions of  Malawi; and 5) 
participation in national policy-level activities pertaining to 
paediatric HIV care. In addition to the comprehensive care 
and treatment provided to paediatric patients at the COE, a 
family clinic has been established whereby the HIV-infected 
child is the point of  entry into the programme for the entire 
family. In the family clinic, HIV-infected adults and siblings 
of  the index child 
also access care at 




p r e s c r i b e d 
cotrimoxazole on 
monthly basis, 
provided with an 
insecticide-treated 
net, and a tablet 
splitter or pill 
cutter since a fixed-
dose combination 
( T r i o m u n e : 
S t a v u d i n e , 
Lamivudine & Niverapine) is the most commonly prescribed 
antiretroviral for paediatric patients in Malawi. A few patients 
are on antiretroviral syrup formulations mainly second line 
regimens, courtesy of  the Clinton Foundation.
The paediatric HIV care training is based on a curriculum 
developed by BIPAI with input from HIV/AIDS health care 
professionals from southern and eastern Africa. The training 
programme in Malawi commenced in October 2006 and to 
date has provided comprehensive paediatric HIV care and 
treatment training to healthcare personnel of  various cadres 
nation-wide5.  In 2007 we trained 813 health professionals; 
111 clinicians (doctors and clinical officers), 20 nurses, 45 
medical assistants, 81 counsellors, 54 pharmacy technicians, 
288 health surveillance assistants, and 7 in other cadres. 
Through a combination of  didactic training and clinical 
mentoring, the training programme aims to support the 
efforts of  the Ministry of  Health to increase the capacity 
of  health centres in the provision and scale-up of  care and 
treatment services to HIV-infected children. An intensive 
one-day training session comprising didactic presentations 
on a range of  clinical, psychosocial and public health topics 
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pertinent to paediatric HIV is held at a district level. A series 
of  follow-up visits to ARV sites in each district are carried 
out, during which Baylor clinicians carry out practical in-clinic 
sessions on direct patient care. In Lilongwe district, outreach 
sites have been established at six national ART sites where 
Baylor clinicians provide HIV care and treatment services 
and mentor clinical staff  at these sites. Clinical officers from 
district health centres where training has been conducted 
spend a week-long attachment at the COE. Attachments 
to the COE, enhances visiting clinicians self  efficacy and 
experience. 
Counselling, testing, and inpatient care
HIV/AIDS testing and counselling (HTC) is one of  the key 
entry points into the programme. The COE and Lighthouse 
Trust HTC counselors work jointly operating from the KCH 
paediatric ward, serving both in-patients and out-patients. 
This has resulted in a reduction in missed opportunities 
for early identification of  HIV-infected children. The COE 
is physically attached to KCH paediatric ward this ensures 
timely identification and enrolment of  both HIV-exposed 
and HIV-infected children. Every effort is made not to offer 
HTC to potential COE patients especially those who are 
admitted to the Nutritional Rehabilitation Unit (NRU) at 
KCH. The COE staff  in the paediatric ward consists  of  
two paediatricians and a nurse who work hand in hand with 
KCH staff  on daily basis to provide comprehensive paediatric 
care to both HIV-infected and uninfected children in the 
ward. The COE is also a recognized outpatient therapeutic 
programme (OTP) site for the management of  moderately 
malnourished HIV-infected children. CD4+ cell counts are 
measured for all HIV infected patients every six months 
while only those who are suspected of  treatment failure have 
their viral loads measured. 
Methods
The programme utilizes multiple data collection methods, 
primarily an electronic medical records (EMR) system.  Data 
were also collected from the following registers; daily patient 
attendance register, new patients register, ARV register,  OTP 
programme (Nutrition) register, and social worker home 
visits (intensive follow up) register. 
An evaluation of  the programme was carried out in 
September 2007, that  utilized two approaches: a two group 
non-randomized pretest post-test (case-control ) to assess 
medical records of  paediatric patients, and a cross-sectional 
study to asses the level of  satisfaction with services provided 
from a sample of  programme users (caregivers and patients) 
and programme staff  (providers). Electronic medical records 
of  129 patients on ARVs and 129 not on ARVs without 
identifiers were reviewed. The evaluation was based on data 
collected from the beginning of  the programme in October 
2004 to June 30, 2007. Selection of  the medical records for 
retrospective review was based on ARV status (either on 
ARVs or not on ARVs). The patients were those registered 
by December 31, 2006 and still active by June 30, 2007 to 
ensure that each patient had data for at least six months.  
Two hundred and twenty-two caregivers (programme users) 
and twenty-one programme staff  (providers) participated in 
face-to-face interviews to gather information on programme 
delivery. Consent was obtained and interviews conducted 
primarily in Chichewa among the caregivers although 
English was used in some cases depending on the literacy 
level of  the caregiver. The evaluation study was approved 
by both the Malawi National Health Sciences Research 
Committee (NHSRC) and the Baylor College of  Medicine 
institutional review board. Data were collected during August 
and September 2007 then analyzed in stages starting with 
descriptive statistics to more advanced procedures. The Chi-
square and Fisher’s exact tests were used to characterize the 
study population. Odds Ratios (OR) were calculated where 
possible to illustrate the strength of  association. Weight-for-
height-and-age percentiles were calculated using Epi-Info 
2000 and World Health Organization reference growth charts 
(WHO 1978 reference). Stata software version 9.0 (College 
station, Texas, USA) was the principal statistical package 
used for data analyses. P-value and 95% confidence interval 
were used to determine levels of  significance. A p-value of  
< 0.05 was considered statistically significant. 
Results 
Description of the cohort 
By June 30 2007, a total of  1917 paediatric patients (<18 
years) and 36 adults had been enrolled in the programme. 
No further analysis was carried out on the adult patients in 
Variable Age category
<18 months 18 months to 5years > 5 years to 18years Total
Sex (N=1917)
Male 340 (50.7%) 302 (53.9%) 355 (51.7%) 997 (52.0%)
Female 330 (49.3%) 258 (46.1%) 332 (48.3%) 920 (48.0%)
Weight for height (n=1056)     
<70% 281 (85.7% 322 (85.4%) 282 (80.3%) 885 (83.8%)
> 70% to 80% 17 (5.2%) 20 (5.3%) 24 (6.9%) 61 (5.8%)
> 80% 30 (9.1%) 35 (9.3%) 45 1(2.8%) 110 (10.4%)
Body mass index (n=798)     
Median  BMI(kg/m²) 
(range) 
Not calculated 15.5 (7.8-20.1) 15.1 (6.1-31.5) 15.1 (6.1-31.5)
Mean BMI Not calculated 15.3 15.2 15.2 (6.1-31.5)
Table 1: Baseline characteristics of the study population
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the family clinic. Mean age at enrolment was 4.2 years and 
median age was 2.5 years [range 0.03-19.1]. About half  of  all 
enrolled paediatric patients (49.9%) had ever been started on 
ARVs by June 30, 2007. Paediatric patient’s gender was male 
(52%) and female (48%). Over eighty percent of  all enrolled 
patients had a weight-for-height-and-age below 70%, and the 
median body mass index (BMI) was 15.1 (6.1-31.5) as shown 
in table 1. 
Over half  (58.1%) the patients were considered active since 
they had attended at least one clinic visit in the preceding 
six months, 17.7% were lost to follow up, 10.5% have died, 
10.6% transferred out, and 3.1% had their files closed after 
ascertainment of  HIV-negative status among HIV-exposed 
infants. Over 80% of  patients reported as “lost to follow-
up” had not been started on ARVs at the time they stopped 
accessing care. Since the start of  the programme in 2004, a 
total of  202 infants and children had died with a majority 
of  the deaths occurring during the first three months of  
enrolment into the programme. Patients aged below five 
years contributed to nearly three-quarters of  the total 
deaths. The majority of  deaths among the patients on ARVs 
occurred during the first three months of  enrolment. Only 
three patients have been stopped from receiving ARVs due to 
poor adherence; none have been discontinued due to adverse 
effects of  ARVs. The median follow up time on ARVs at the 
COE was 42 weeks, range (0 – 136 weeks). 
Only thirty-nine patients had viral loads done by June 2007 
due to suspected immunologic failure of  whom twenty-
five of  them had detectable viral load (>400 copies/ml) 
and fourteen had undetectable viral load (<400 copies/
ml). A total of  fifty patients had been switched from the 
standard first-line regimen in Malawi (Triomune: Stavudine, 
Lamivudine & Niverapine) to either an alternative first-line 
(22 patients) or a second line (28 patients) regimen. Main 
reasons for change of  ART regimen to alternative first-line 
were hypersensitivity to Niverapine, peripheral neuropathy, 
and pancreatitis.
Comparison by ARV status
Table 2 summarizes the comparison of  the two groups on 
key demographic and clinical characteristics. A total of  258 
medical records were reviewed; 129 on ARVs and 129 not 
on ARVs.  Mean age at enrolment in each of  the two groups 
was 4.8 years. The proportion of  males among those on 
ARVs (59%) was significantly higher than among those not 
on ARVs (36%), and males were 2.6 times more likely to be 
on ARVs compared to females (p<0.05). Patients who had 
a confirmed HIV-positive diagnosis at enrolment were 2.5 
times more likely to have been on ARVs compared to those 
who were HIV-exposed at enrolment (p<0.05). Patients in 
either WHO stage III or IV at enrolment were 11.1 times 
more likely to be on ARVs compared to those in either 
WHO stage I or II (p<0.05).  Presence of  malnutrition was 
more pronounced among those on ARVs. Baseline absolute 
CD4+ cell count and percent was significantly lower (about 
half) among patients on ARVs compared to those not on 
ARVs (p<0.05).  Both the mean absolute CD4+ and percent 
doubled from 562 to 1280 cells/mm3 and 14% to 28% 
respectively in nearly thirty months (p<0.05) among patients 
on ARVs.  
Interviews
Nearly 90% of  the caregivers (programme users) were 
females, and 65% of  the caregivers were the reported 
biological mother of  the child/patient. Other caregivers 
included aunts (12.6%), fathers (5.9%), grandmothers (5%), 
and sisters (4%).  About half  of  the caregivers either had 
no formal schooling or only primary level education. Only 
about half  of  the caregivers were employed (full time or 
self  employment) while 42.3% were unemployed. Table 3 
shows that the level of  satisfaction of  services offered by 
the programme as reported by programme users and the 
providers. The programme users reported being very satisfied 
while the providers reported being satisfied with the services 
provided.  None of  the respondents reported being either 
unsatisfied or very unsatisfied with the programme.  
Discussion
The new paediatric clinic facility has not only increased 
the ability of  the staff  to attend to more patients, but has 
also provided an environment conducive to providing 
optimal paediatric HIV care as well as training of  health 
care personnel of  different cadres on paediatric HIV/
AIDS. Laboratory services that include CD4+ cell count, 
HIV RNA measurements and chemistries are provided by 
Table 2: Comparison of demographic and clinical factors by ARV status 
         
 
Variable Proportions and means
On ARVs    No ARVs Odds 
ratio
p-value
Sex Male=59% Male=36% 2.6 <0.05
Age at enrolment
μ=4.8 years μ=4.8 years 0.70
HIV-infected at 
enrolment
91% 81% 2.5 <0.05
Received PMTCT 
(sdNVP)
29% 21% 0.6 0.14
WHO stages 3 & 4 85% 34% 11.1 <0.05
Malnutrition 
present
10% 6% 1.8 <0.05
PCP prophylaxis 98% 99% 0.8 0.51







* One cell had less than 5 members; Fisher’s exact p-value quoted.
All  other p-values are Chi2







Very satisfied (5) 1 2 171
Satisfied (4) 8 9 46
Neutral (3) 0 1 3
Unsatisfied (2) 0 0 0
Very unsatisfied (1) 0 0 0
Mean 4.1 4.1 4.8
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KCH free of  charge and also by the UNC Project at a fee 
borne by the programme to facilitate early staging, diagnosis 
and management of  the patients. Without this kind of  
collaboration between various partner and stakeholders, it 
would not have been possible for the programme to offer 
such high quality and specialized service to a great number of  
children in such a short time since these essential laboratory 
services are not yet available at the COE. Since very few 
healthcare facilities in Malawi have this level of  both material 
and human resources, training of  health care cadres other 
than medical doctors in paediatric HIV care has proved to be 
a key component of  the programme in the process of  scaling 
up paediatric HIV care in Malawi and ensuring sustainability 
of  the programme after the American paediatricians have 
left Malawi. We have learned that training other cadres of  
healthcare personnel on paediatric HIV care is feasible, 
affordable, and a way of  ensuring sustainability of  paediatric 
HIV care within the Malawi healthcare system.       
Outcomes of  this programme indicate that there is a clear 
benefit of  providing ARVs to HIV-infected children. The 
baseline mean absolute CD4+ and percent nearly doubled 
from 562 to 1280 cells/mm3 and 14% to 28% respectively 
in period of  about two years. It was however not possible 
to explore the temporal relationship between immunologic 
changes (laboratory data) and clinical outcomes since we 
could not clearly link the laboratory dates to specific clinic 
visits such as 6th month, 12th month, 18th month visit and 
so on. Furthermore, only thirty-nine patients were referred 
for viral load testing suggesting that CD4 cell monitoring is 
an effective tool of  monitoring ART in children. 
The early mortality (first three months) reported in this study 
is in agreement with findings from a study on risk factors for 
early mortality in children on fixed-dose combination ART 
reported from Malawi6. Early identification and prompt 
management of  HIV-infected children is key to reducing 
early mortality.  In a study carried out in the Southern part of  
Malawi, Zachariah et.al7 concluded that community support 
might be associated with a considerably low death rate and 
overall better ART outcomes. An extension of  the Baylor 
programme towards provision of  community support may 
help reduce the early mortality in a similar manner. 
The success of  this programme in Malawi, and similar 
programmes sponsored by BIPAI in eight African countries 
has demonstrated that ART can be administered safely and 
effectively in developing countries. The expertise provided 
by the multidisciplinary programme staff, dedication shown 
by the caregivers and the continued support by programme 
partners has ensured that the programme continues to 
grow and provide hope to HIV-infected and HIV-exposed 
Malawian children. This programme is a testimony of  
reduction in stigma and discrimination associated with 
HIV/AIDS in Malawi, as evidenced by the fact that 
hundreds of  patients accessing services from a facility that is 
publicly known to be dedicated to paediatric HIV care. This 
programme has demonstrated that ART can be administered 
safely and effectively to children, and provides a forum for 
more elaborate and sustained response to paediatric HIV/
AIDS care in Malawi. 
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